Esperion Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since December 2024 -- Data Talk

Dow Jones
10/09

Esperion Therapeutics, Inc. ( ESPR ) is currently at $2.60, down $0.49 or 15.7%

 

--Would be lowest close since Sept. 25, 2025, when it closed at $2.56

--On pace for largest percent decrease since Dec. 10, 2024, when it fell 20.63%

--Currently down three consecutive days; down 21.06% over this period

--Worst three day stretch since the three days ending Dec. 13, 2024, when it fell 25.99%

--Down 1.7% month-to-date

--Up 18.41% year-to-date; on pace for best year since 2022, when it rose 24.6%

--Down 97.74% from its all-time closing high of $115.30 on May 19, 2015

--Up 34.97% from 52 weeks ago (Oct. 9, 2024), when it closed at $1.93

--Down 31.98% from its 52-week closing high of $3.83 on Dec. 9, 2024

--Up 256.85% from its 52-week closing low of $0.73 on May 14, 2025

--Traded as low as $2.30; lowest intraday level since Sept. 3, 2025, when it hit $2.26

--Down 25.57% at today's intraday low; largest intraday percent decrease since Dec. 13, 2024, when it fell as much as 27.84%

 

All data as of 3:05:52 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 08, 2025 15:10 ET (19:10 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10